Study S003253

A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of the Oxyntomodulin Analog, LY2944876, in Healthy Japanese Subjects and Healthy Non-Japanese Subjects

ClinicalTrials.gov record

Registration

Registration: NCT02188303
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: DOUBLE
Status: TERMINATED
Enrollment: 48
Start: 2014-07
Primary completion: 2014-12
Lead sponsor: OPKO Health, Inc.
Conditions: Healthy Volunteers
Interventions: DRUG:LY2944876; DRUG:Placebo
Results posted: TRUE
Secondary identifiers: OTHER:I7I-EW-XNAB

Registered primary outcomes

Number of Participants With One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to Be Related to Study Drug Administration [Pre-dose (PRD) through Study Completion (Up to Day 40)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.